Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mucin-12 (MUC12) is an integral membrane glycoprotein belonging to the mucin family, characterized by extensive O-glycosylation, the presence of EGF-like domains, and localization on the epithelial cell surface[1][3][9]. It plays roles in the protection of epithelial cells, modulation of cell adhesion, and cell signaling, and may be involved in regulating epithelial cell growth[1][9]. Expression of MUC12 has been documented in various epithelial tissues, and it has been reported to be down-regulated in certain colorectal cancers[8]. Unlike some more extensively studied mucins, there are no known approved drugs or targeted therapeutics directed at MUC12, nor is it widely used as a clinical biomarker.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mucin-12, cell surface associated (MUC12).